A detailed history of Lewis Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lewis Asset Management, LLC holds 1,181 shares of LLY stock, worth $906,724. This represents 0.76% of its overall portfolio holdings.

Number of Shares
1,181
Previous 1,181 -0.0%
Holding current value
$906,724
Previous $1.07 Billion 2.15%
% of portfolio
0.76%
Previous 0.82%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$724.87 - $909.04 $7,248 - $9,090
-10 Reduced 0.84%
1,181 $1.07 Billion
Q1 2024

May 01, 2024

BUY
$592.2 - $792.28 $6,514 - $8,715
11 Added 0.93%
1,191 $927 Million
Q4 2023

Jan 23, 2024

BUY
$525.19 - $619.13 $619,724 - $730,573
1,180 New
1,180 $688 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lewis Asset Management, LLC Portfolio

Follow Lewis Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lewis Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lewis Asset Management, LLC with notifications on news.